N-Power Medicine Revenue and Competitors

Location

#6225

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • N-Power Medicine's estimated annual revenue is currently $20.3M per year.(i)
  • N-Power Medicine's estimated revenue per employee is $189,766
  • N-Power Medicine's total funding is $72M.

Employee Data

  • N-Power Medicine has 107 Employees.(i)
  • N-Power Medicine grew their employee count by 37% last year.

N-Power Medicine's People

NameTitleEmail/Phone
1
CEO & Co-FounderReveal Email/Phone
2
Co-founder, Head Clinical ScienceReveal Email/Phone
3
Chief Staff and Head IntegrationReveal Email/Phone
4
Head ComplianceReveal Email/Phone
5
Sr. Marketing and Contracts ManagerReveal Email/Phone
6
Senior Manager, Security and PrivacyReveal Email/Phone
7
Quality Systems ManagerReveal Email/Phone
8
Virtual Physician Partner ManagerReveal Email/Phone
9
Program ManagementReveal Email/Phone
10
Head, Data Science & TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is N-Power Medicine?

N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors.\n\nThe N-Power Platform consists of: \n- The real-time Kaleido™ Registry, conducted with patient consent, that defines \n standardized data collection at the point of care and is malleable to partner \n needs, \n- A technology solution that enables data collection and analysis, and\n- Embedded on-site and virtual staff who support delivery of routine care, \n implement standardized, registry protocol-defined data collection and augment \n site staff in clinical research. \n\nBy partnering with oncologists, research staff and patients in unlocking the full potential of every patient’s data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development.

keywords:N/A

$72M

Total Funding

107

Number of Employees

$20.3M

Revenue (est)

37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16M1102%$24.2M
#2
$17.1M110-25%$656.6M
#3
$13.4M11220%N/A
#4
$22.6M112-4%N/A
#5
$7.8M112-19%$56M